TY - JOUR
T1 - Binding of 3H-naloxone in the mouse brain
T2 - Effect of ions and tolerance development
AU - Hitzemann, Robert J.
AU - Hitzemann, Barbara A.
AU - Loh, Horace H.
N1 - Funding Information:
1 This study was supported in part by USPHS Grant DA-00564 and Contract DADA-17-73-C-03006 .
PY - 1974/6/16
Y1 - 1974/6/16
N2 - The binding of 3H-naloxone (spec. act. 5.2 Ci/mmol) in a crude mitochondrial fraction of the whole mouse brain was examined. Binding was reversed by the narcotic agonists levorphanol, morphine and 1-methadone but not by dextrorphan. Levorphanol sensitive (specific) 3H-naloxone binding was blocked by Na+, Li+, Ca++, Mg++ and Mn++ but not by K+. When the crude mitochondrial fraction was separated on a discontinuous sucrose gradient, the highest activity of specific binding was found in the nerve ending particle fraction. Animals made physically dependent by 3 day morphine pellet implantation did not show an increased binding affinity for 3H-nalovxone. The implantation of a 10 mg naloxone pellet increased the apparent total number of binding sites on the second and third day of implantation.
AB - The binding of 3H-naloxone (spec. act. 5.2 Ci/mmol) in a crude mitochondrial fraction of the whole mouse brain was examined. Binding was reversed by the narcotic agonists levorphanol, morphine and 1-methadone but not by dextrorphan. Levorphanol sensitive (specific) 3H-naloxone binding was blocked by Na+, Li+, Ca++, Mg++ and Mn++ but not by K+. When the crude mitochondrial fraction was separated on a discontinuous sucrose gradient, the highest activity of specific binding was found in the nerve ending particle fraction. Animals made physically dependent by 3 day morphine pellet implantation did not show an increased binding affinity for 3H-nalovxone. The implantation of a 10 mg naloxone pellet increased the apparent total number of binding sites on the second and third day of implantation.
UR - http://www.scopus.com/inward/record.url?scp=0016133734&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016133734&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(74)90135-0
DO - 10.1016/0024-3205(74)90135-0
M3 - Article
C2 - 4549965
AN - SCOPUS:0016133734
SN - 0024-3205
VL - 14
SP - 2393
EP - 2404
JO - Life Sciences
JF - Life Sciences
IS - 12
ER -